27510556|t|Natural product derivative BIO promotes recovery after myocardial infarction via unique modulation of the cardiac microenvironment
27510556|a|The cardiac microenvironment includes cardiomyocytes, fibroblasts and macrophages, which regulate remodeling after myocardial infarction (MI). Targeting this microenvironment is a novel therapeutic approach for MI. We found that the natural compound derivative, BIO ((2'Z,3'E)-6-Bromoindirubin-3'-oxime) modulated the cardiac microenvironment to exert a therapeutic effect on MI. Using a series of co-culture studies, BIO induced proliferation in cardiomyocytes and inhibited proliferation in cardiac fibroblasts. BIO produced multiple anti-fibrotic effects in cardiac fibroblasts. In macrophages, BIO inhibited the expression of pro-inflammatory factors. Significantly, BIO modulated the molecular crosstalk between cardiac fibroblasts and differentiating macrophages to induce polarization to the anti-inflammatory M2 phenotype. In the optically transparent zebrafish-based heart failure model, BIO induced cardiomyocyte proliferation and completely recovered survival rate. BIO is a known glycogen synthase kinase-3β inhibitor, but these effects could not be recapitulated using the classical inhibitor, lithium chloride; indicating novel therapeutic effects of BIO. We identified the mechanism of BIO as differential modulation of p27 protein expression and potent induction of anti-inflammatory interleukin-10. In a rat MI model, BIO reduced fibrosis and improved cardiac performance. Histological analysis revealed modulation of the cardiac microenvironment by BIO, with increased presence of anti-inflammatory M2 macrophages. Our results demonstrate that BIO produces unique effects in the cardiac microenvironment to promote recovery post-MI.
27510556	0	26	Natural product derivative	T103	UMLS:C1566558
27510556	27	30	BIO	T103	UMLS:C1254351
27510556	40	48	recovery	T038	UMLS:C2004454
27510556	55	76	myocardial infarction	T038	UMLS:C0027051
27510556	88	98	modulation	T082	UMLS:C0443264
27510556	106	113	cardiac	T017	UMLS:C0018787
27510556	135	142	cardiac	T017	UMLS:C0018787
27510556	169	183	cardiomyocytes	T017	UMLS:C0225828
27510556	185	196	fibroblasts	T017	UMLS:C0016030
27510556	201	212	macrophages	T017	UMLS:C0024432
27510556	220	228	regulate	T038	UMLS:C1327622
27510556	229	239	remodeling	T038	UMLS:C3658220
27510556	246	267	myocardial infarction	T038	UMLS:C0027051
27510556	269	271	MI	T038	UMLS:C0027051
27510556	317	337	therapeutic approach	T058	UMLS:C0087111
27510556	342	344	MI	T038	UMLS:C0027051
27510556	364	391	natural compound derivative	T103	UMLS:C1566558
27510556	393	396	BIO	T103	UMLS:C1254351
27510556	397	434	((2'Z,3'E)-6-Bromoindirubin-3'-oxime)	T103	UMLS:C1254351
27510556	435	444	modulated	T082	UMLS:C0443264
27510556	449	456	cardiac	T017	UMLS:C0018787
27510556	485	503	therapeutic effect	T201	UMLS:C1527144
27510556	507	509	MI	T038	UMLS:C0027051
27510556	529	547	co-culture studies	T058	UMLS:C0282547
27510556	549	552	BIO	T103	UMLS:C1254351
27510556	561	574	proliferation	T038	UMLS:C0596290
27510556	578	592	cardiomyocytes	T017	UMLS:C0225828
27510556	607	620	proliferation	T038	UMLS:C0596290
27510556	624	631	cardiac	T017	UMLS:C0018787
27510556	632	643	fibroblasts	T017	UMLS:C0016030
27510556	645	648	BIO	T103	UMLS:C1254351
27510556	667	688	anti-fibrotic effects	T033	UMLS:C0243095
27510556	692	699	cardiac	T017	UMLS:C0018787
27510556	700	711	fibroblasts	T017	UMLS:C0016030
27510556	716	727	macrophages	T017	UMLS:C0024432
27510556	729	732	BIO	T103	UMLS:C1254351
27510556	802	805	BIO	T103	UMLS:C1254351
27510556	806	815	modulated	T082	UMLS:C0443264
27510556	830	839	crosstalk	T038	UMLS:C0010357
27510556	848	855	cardiac	T017	UMLS:C0018787
27510556	856	867	fibroblasts	T017	UMLS:C0016030
27510556	888	899	macrophages	T017	UMLS:C0024432
27510556	910	922	polarization	T038	UMLS:C0007613
27510556	930	947	anti-inflammatory	T033	UMLS:C0243095
27510556	948	950	M2	T017	UMLS:C4086555
27510556	969	1026	optically transparent zebrafish-based heart failure model	T170	UMLS:C3161035
27510556	1028	1031	BIO	T103	UMLS:C1254351
27510556	1040	1053	cardiomyocyte	T017	UMLS:C0225828
27510556	1054	1067	proliferation	T038	UMLS:C0596290
27510556	1108	1111	BIO	T103	UMLS:C1254351
27510556	1123	1150	glycogen synthase kinase-3β	T103	UMLS:C0244988
27510556	1151	1160	inhibitor	T103	UMLS:C0243077
27510556	1217	1236	classical inhibitor	T103	UMLS:C0243077
27510556	1238	1254	lithium chloride	T103	UMLS:C0065088
27510556	1273	1292	therapeutic effects	T201	UMLS:C1527144
27510556	1296	1299	BIO	T103	UMLS:C1254351
27510556	1332	1335	BIO	T103	UMLS:C1254351
27510556	1352	1362	modulation	T082	UMLS:C0443264
27510556	1366	1369	p27	T103	UMLS:C0598086
27510556	1370	1388	protein expression	T038	UMLS:C1171362
27510556	1413	1430	anti-inflammatory	T033	UMLS:C0243095
27510556	1431	1445	interleukin-10	T103	UMLS:C0085295
27510556	1452	1464	rat MI model	T170	UMLS:C0086272
27510556	1466	1469	BIO	T103	UMLS:C1254351
27510556	1478	1486	fibrosis	T038	UMLS:C0016059
27510556	1491	1499	improved	T033	UMLS:C0184511
27510556	1500	1507	cardiac	T017	UMLS:C0018787
27510556	1534	1542	analysis	T062	UMLS:C0936012
27510556	1552	1562	modulation	T082	UMLS:C0443264
27510556	1570	1577	cardiac	T017	UMLS:C0018787
27510556	1598	1601	BIO	T103	UMLS:C1254351
27510556	1618	1626	presence	T033	UMLS:C0150312
27510556	1630	1647	anti-inflammatory	T033	UMLS:C0243095
27510556	1648	1662	M2 macrophages	T017	UMLS:C4086555
27510556	1693	1696	BIO	T103	UMLS:C1254351
27510556	1728	1735	cardiac	T017	UMLS:C0018787
27510556	1764	1772	recovery	T038	UMLS:C2004454